chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Blood glucose decreased, Chills, Headache, Hyperhidrosis
Clinical narrative: headache; sweats; feverish; chills; low blood sugar symptoms; weakness; This is a spontaneous report from a contactable healthcare professional. This 66-year-old female patient received 2nd dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot EL3247) on 24Jan2021 at 11:15 AM at left arm for COVID-19 immunization in hospital. Historical vaccine included first dose for BNT162B2 (lot EK5730) on 02Jan2021 at 11:30 AM at left arm for COVID-19 immunization. Medical history included hypo thyroid, parox afib, high blood pressure (HBP), obesity and allergies: bupropion hydrochloride (WELLBUTRIN), soy. Concomitant drugs included metoprolol, apixaban (ELIQUIS), fluoxetine hydrochloride (PROZAC), losartan potassium (COZAAR), thyroid (ARMOUR THYROID) and more. On the day of injection on 24Jan2021 at 04:00 PM, the patient had low blood sugar symptoms, weakness, which resolved in a few hours. On second day, symptoms of low Blood sugar, sweats, feverish, chills, on third day feverish symptoms of low blood sugar, sweats, feverish, headache.  No treatment was received. The outcome the events was unknown.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: headache; sweats; feverish; chills; low blood sugar symptoms; weakness; This is a spontaneous report from a contactable healthcare professional. This 66-year-old female patient received 2nd dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot EL3247) on 24Jan2021 at 11:15 AM at left arm for COVID-19 immunization in hospital. Historical vaccine included first dose for BNT162B2 (lot EK5730) on 02Jan2021 at 11:30 AM at left arm for COVID-19 immunization. Medical history included hypo thyroid, parox afib, high blood pressure (HBP), obesity and allergies: bupropion hydrochloride (WELLBUTRIN), soy. Concomitant drugs included metoprolol, apixaban (ELIQUIS), fluoxetine hydrochloride (PROZAC), losartan potassium (COZAAR), thyroid (ARMOUR THYROID) and more. On the day of injection on 24Jan2021 at 04:00 PM, the patient had low blood sugar symptoms, weakness, which resolved in a few hours. On second day, symptoms of low Blood sugar, sweats, feverish, chills, on third day feverish symptoms of low blood sugar, sweats, feverish, headache.  No treatment was received. The outcome the events was unknown.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Body temperature, Chills, Fatigue, Headache
Clinical narrative: Fatigue; Headache; fever (~100F); joint pain; chills; facial rash (flat, bright red rash on both cheeks and chin); This is a spontaneous report from a contactable consumer (patient).  A 32-years-old female patient (not pregnant) received 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot: EL8982), via an unspecified route of administration on 24Jan2021 at 12:15 at single dose in left arm for COVID-19 immunisation. Medical history included depression and anxiety. Concomitant medication included sertraline and buspirone, both from unknown date for unknown indication. The patient experienced fatigue, headache, fever (~100f), joint pain, chills, facial rash (flat, bright red rash on both cheeks and chin), all on 24Jan2021 18:30 with outcome of recovering. No treatment was received. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient had not been tested for COVID-19. This case was reported as non-serious.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Rash
Clinical narrative: Fatigue; Headache; fever (~100F); joint pain; chills; facial rash (flat, bright red rash on both cheeks and chin); This is a spontaneous report from a contactable consumer (patient).  A 32-years-old female patient (not pregnant) received 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot: EL8982), via an unspecified route of administration on 24Jan2021 at 12:15 at single dose in left arm for COVID-19 immunisation. Medical history included depression and anxiety. Concomitant medication included sertraline and buspirone, both from unknown date for unknown indication. The patient experienced fatigue, headache, fever (~100f), joint pain, chills, facial rash (flat, bright red rash on both cheeks and chin), all on 24Jan2021 18:30 with outcome of recovering. No treatment was received. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient had not been tested for COVID-19. This case was reported as non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia, Swelling face
Clinical narrative: swelling/tingly on her right facial cheek; swelling/tingly on her right facial cheek; This is a spontaneous report from a contactable Other HCP (patient). This 40-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) at single dose on 21Jan2021 for COVID-19 immunisation. Medical history included rosacea. Concomitant medication was not reported. Patient received vaccine on Thursday and had been experiencing swelling/tingly on her right facial cheek.  She saw both her PCP and dermatologist and has a history of rosacea.  Her dermatologist told her to take cetirizine hydrochloride (ZYRTEC) for a week. Patient asked if this was a reported side effect, the efficacy after one dose; if could get second dose after having a reaction to the first vaccine; efficacy against other variants of the virus; information on rosacea/ autoimmune patients. The outcome of events was unknown.  Information on the lot/batch number has been requested.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Headache, Nausea, Pain
Clinical narrative: Body aches; Joint pains; Chills; Right arm injection muscular pain radiating to elbow; Slight nausea; Slight headache; Right arm injection muscular pain radiating to elbow; This is a spontaneous report from a contactable Nurse. This 51-year-old female Nurse (patient) reported for herself that she received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number=EL3246), intramuscular at right arm on 25Jan2021 15:30 at single dose for COVID-19 immunization. Facility type vaccine: Hospital. Medical history included HTN, cholesterol, known allergies: sulfa. Historical vaccine included the first dose of BNT162B2 (lot number=EJ1686) on 04Jan2021 13:00 via intramuscular at left arm for COVID-19 immunization. Concomitant medication included amlodipine, rosuvastatin calcium (CRESTOR), clonazepam.  On 26Jan2021 12:00, patient had body aches, joint pains, chills, right arm injection muscular pain radiating to elbow, slight nausea, slight headache with outcome of unknown. No treatment was received. The patient underwent lab tests included COVID-19 virus test (nasal swab): negative on 10Jan2021. Patient was not pregnant. No other vaccine in four weeks. No covid prior vaccination.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, SARS-CoV-2 test, Vaccination site pain
Clinical narrative: Body aches; Joint pains; Chills; Right arm injection muscular pain radiating to elbow; Slight nausea; Slight headache; Right arm injection muscular pain radiating to elbow; This is a spontaneous report from a contactable Nurse. This 51-year-old female Nurse (patient) reported for herself that she received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number=EL3246), intramuscular at right arm on 25Jan2021 15:30 at single dose for COVID-19 immunization. Facility type vaccine: Hospital. Medical history included HTN, cholesterol, known allergies: sulfa. Historical vaccine included the first dose of BNT162B2 (lot number=EJ1686) on 04Jan2021 13:00 via intramuscular at left arm for COVID-19 immunization. Concomitant medication included amlodipine, rosuvastatin calcium (CRESTOR), clonazepam.  On 26Jan2021 12:00, patient had body aches, joint pains, chills, right arm injection muscular pain radiating to elbow, slight nausea, slight headache with outcome of unknown. No treatment was received. The patient underwent lab tests included COVID-19 virus test (nasal swab): negative on 10Jan2021. Patient was not pregnant. No other vaccine in four weeks. No covid prior vaccination.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: diarrhea; This is a spontaneous report from a contactable consumer (patient). A 75-year-old male patient received his 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EL9261) at single dose on 22Jan2021 about 14:40 intramuscular in right shoulder for COVID-19 vaccination. Medical history, concomitant drugs, and family medical history relevant to event were reported as "none". Patient had no history of all previous immunization with the Pfizer vaccine considered as suspect, no additional Vaccines Administered on Same Date of the Pfizer Suspect, no prior vaccinations (within 4 weeks), no relevant tests. Patient experienced diarrhea at about 8-9am 25Jan2021. Patient reported that he had had diarrhea for the last 24 hours (as of 26Jan2021). It started on 25Jan2021.  Patient stated that his diarrhea did not go away. Usually he would go to the bathroom 3-4 times and it would go away, but this was not going away. No investigation assessment performed. The event did not require a visit to Emergency Room/ Physician Office. Outcome of the event was not resolved.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Back pain, Chest pain, Dizziness, Neck pain
Clinical narrative: Neck/back chest pain; Neck/back chest pain; Neck/back chest pain; dizzy; weak; fever; This is a spontaneous report from a contactable nurse (the patient). This 43-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number: EL9262), dose 2, single dose via an unspecified route of administration in the left arm  on 26Jan2021 at 10:00 AM (at the age of 43- years-old) for COVID-19 vaccination. The patient's medical history included hypertension, hyperlidemia, pre-cancer cells in cervix, hysterectomy and allergy to penicillin. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number: ELO1423, expiration: 1/2021), single dose, dose 1  in the right arm on 05Jan2021 at 10:00 AM. Concomitant medications included atorvastatin, hydrochlorothiazide, losartan potassium (LOSARTAN/HCTZ), fluoxetine (PROZAC) and zolpidem (AMBIEN). On 27Jan2021, the patient had neck, back and chest pain, dizzy, weak and fever.  The events were reported as non-serious. Prior to the vaccination, the patient was not diagnosed with COVID-19.  The patient did not receive any other vaccine within 4 weeks prior to the vaccine. No therapeutic measures were taken as a result of neck, back and chest pain, dizzy, weak and fever.  The clinical outcome of neck, back and chest pain, dizzy, weak and fever was not recovered . The patient has been tested for COVID-19 since having the vaccine. On 25Jan2021, COVID rapid test was negative.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test
Clinical narrative: Neck/back chest pain; Neck/back chest pain; Neck/back chest pain; dizzy; weak; fever; This is a spontaneous report from a contactable nurse (the patient). This 43-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number: EL9262), dose 2, single dose via an unspecified route of administration in the left arm  on 26Jan2021 at 10:00 AM (at the age of 43- years-old) for COVID-19 vaccination. The patient's medical history included hypertension, hyperlidemia, pre-cancer cells in cervix, hysterectomy and allergy to penicillin. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number: ELO1423, expiration: 1/2021), single dose, dose 1  in the right arm on 05Jan2021 at 10:00 AM. Concomitant medications included atorvastatin, hydrochlorothiazide, losartan potassium (LOSARTAN/HCTZ), fluoxetine (PROZAC) and zolpidem (AMBIEN). On 27Jan2021, the patient had neck, back and chest pain, dizzy, weak and fever.  The events were reported as non-serious. Prior to the vaccination, the patient was not diagnosed with COVID-19.  The patient did not receive any other vaccine within 4 weeks prior to the vaccine. No therapeutic measures were taken as a result of neck, back and chest pain, dizzy, weak and fever.  The clinical outcome of neck, back and chest pain, dizzy, weak and fever was not recovered . The patient has been tested for COVID-19 since having the vaccine. On 25Jan2021, COVID rapid test was negative.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Discomfort, Migraine, Ocular discomfort
Clinical narrative: 1st dose: 24 hrs after administration, I developed a searing migraine that lasted for approx 15 hours. No medications could touch the pain and it felt like my brain and eyeballs were going to explore; 1st dose: 24 hours after administration, I developed a searing migraine that lasted for approx 15 hours. No medications could touch the pain and it felt like my brain and eyeballs were going to explor; 1st dose: 24 hours after administration, I developed a searing migraine that lasted for approx 15 hours. No medications could touch the pain and it felt like my brain and eyeballs were going to explor; This is a spontaneous report from a contactable self-reporting other health professional.  A 36-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot number EJ1686), intramuscularly on an unspecified date in Jan2021 at 13:00  (at the age of 36-years-old) as a single dose in the left arm for COVID-19 vaccination. Medical history included anaphylactic reactions to penicillin and pistachios. The patient was not pregnant at the time of vaccination.  Prior to the vaccination, the patient was not diagnosed with COVID-19.  Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. The vaccine was administered to the patient in a hospital. The patient reported that twenty-four hours after administration she developed a searing migraine that lasted for approximately fifteen hours. She stated that "no medications could touch the pain" and it felt like her brain and eyeballs were going to explode.  The patient specified that she did not receive any treatment for the events. The clinical outcomes of migraine, sensation of pressure and eye discomfort were reported as recovering. It was also reported that since the vaccination, the patient had not been tested for COVID-19.  No follow-up attempts are possible. No further information is expected.
Age: 91.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Vomiting
Clinical narrative: diarrhea; vomiting; This is a spontaneous report from a contactable consumer (patient). A 91-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration on 20Jan2021 at 11:45 (at the age of 91-years-old) as a single dose in the left arm for COVID-19 immunization (tired of being cooped up in the house). Medical history included atrial fibrillation and patient had a pacemaker, both from an unknown date. Concomitant medications were not reported. The patient did not receive other vaccines within four weeks prior to vaccination. On 25Jan2021, at night, the patient experienced diarrhea and vomiting. The clinical outcome of the events diarrhea and vomiting was recovered on 26Jan2021 at 02:00 and she felt good.    The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Neck pain, Vaccination site pain
Clinical narrative: Left arm very sore up through left neck; Left arm very sore up through left neck; This is a spontaneous report from a contactable consumer (patient). This 53-year-old non-pregnant female patient received the first dose of BNT12B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; lot number EL9264) via an unknown route of administration in the left arm on 26Jan2021 (at the age of 53-years-old) at 3:30 PM as a single dose for COVID-19 immunization. The patient's medical history included hypertension and penicillin allergy, both from unknown dates and unknown if ongoing. The patient's concomitant medications included hydrochlorothiazide, valsartan (DIOVAN HCT) from an unknown date for an unknown indication; amlodipine from an unknown date for an unknown indication; fish oil from an unknown date for an unknown indication; and vitamin B complex (VITAMIN B 50) from an unknown date for an unknown indication. The patient previously took levofloxacin (LEVOQUIN) on an unknown date for an unknown indication and experienced allergies; and influenza vaccine on an unknown date for an unknown indication and experienced pain. The patient had not received any other vaccines in the 4 weeks prior to the COVID vaccine. The patient reported experiencing left arm very sore up through left neck; not red just aching and pain through the first night post injection. The patient reported being still sore on day two; much more pain than flu shot previous experience. The event was reported as non-serious and did not require hospitalization. Therapeutic measures were taken as a result of the events and included treatment with ibuprofen. The clinical outcomes of left arm very sore up through left neck were recovering. It was also reported the patient was not diagnosed with COVID-19 prior to vaccination and that the patient had not been tested for COVID-19 since vaccination.  No follow-up attempts are possible. No further information is expected.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Sore arm at injection site; This is a spontaneous report from a contactable consumer (patient). A 31-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration (left arm) on 26Jan2021 09:00 (at the age of 31years) at single dose for Covid-19 immunization. The patient's medical history included Covid-19 (prior to vaccination the patient diagnosed with COVID-19). Concomitant medications included cetirizine hydrochloride (ZYRTEC) and fluticasone propionate (FLONASE); both from an unspecified date for an unspecified indication. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 27Jan2021 07:00, the patient experienced sore arm at injection site. There was no treatment received for the adverse event. The patient has not been tested for COVID-19 since the vaccination. The outcome of event was recovering. This case is non-serious.  Information on the lot/batch number has been requested.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Lymph node pain, Lymphadenopathy
Clinical narrative: Fever; Chills; Muscle aches; Swollen PAINFUL lymph nodes left armpit; Swollen PAINFUL lymph nodes left armpit; tingling left wrist; headache; fatigue; This is a spontaneous report from a contactable nurse (patient). A 28-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot number: el9261) via an unspecified route of administration on the left arm on 25Jan2021 14:30 at a single dose for COVID-19 immunization. The patient medical history was not reported. Concomitant medication included drospirenone, ethinylestradiol (NIKKI) for birth control. The patient previously received first dose of BNT162B2 on 04Jan2021 for COVID-19 immunization (lot number: ej1685, left arm, 02:00 PM). On 26Jan2021 04:00 AM, the patient experienced fever, chills, Muscle aches, swollen painful lymph nodes left armpit, tingling left wrist, headache, fatigue. No treatment was received for the events. Events were reported as non-serious: did not result in death, was not life-threatening, did not cause/prolonged hospitalization, was not disabling/incapacitating and did not cause congenital anomaly/birth defect. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient was not pregnant. Post vaccination, the patient has been tested for COVID-19, nasal swab on 25Jan2021: pending result. Prior to vaccination, the patient was not diagnosed with COVID-19. Patient had no allergies to medications, food, or other products. The facility where the vaccine was administered was in a Public Health Clinic/Veterans Administration facility. Outcome of the events was not recovered.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Paraesthesia, Pyrexia, SARS-CoV-2 test
Clinical narrative: Fever; Chills; Muscle aches; Swollen PAINFUL lymph nodes left armpit; Swollen PAINFUL lymph nodes left armpit; tingling left wrist; headache; fatigue; This is a spontaneous report from a contactable nurse (patient). A 28-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot number: el9261) via an unspecified route of administration on the left arm on 25Jan2021 14:30 at a single dose for COVID-19 immunization. The patient medical history was not reported. Concomitant medication included drospirenone, ethinylestradiol (NIKKI) for birth control. The patient previously received first dose of BNT162B2 on 04Jan2021 for COVID-19 immunization (lot number: ej1685, left arm, 02:00 PM). On 26Jan2021 04:00 AM, the patient experienced fever, chills, Muscle aches, swollen painful lymph nodes left armpit, tingling left wrist, headache, fatigue. No treatment was received for the events. Events were reported as non-serious: did not result in death, was not life-threatening, did not cause/prolonged hospitalization, was not disabling/incapacitating and did not cause congenital anomaly/birth defect. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient was not pregnant. Post vaccination, the patient has been tested for COVID-19, nasal swab on 25Jan2021: pending result. Prior to vaccination, the patient was not diagnosed with COVID-19. Patient had no allergies to medications, food, or other products. The facility where the vaccine was administered was in a Public Health Clinic/Veterans Administration facility. Outcome of the events was not recovered.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Balance disorder, Dizziness
Clinical narrative: felt a little dizzy / If she moves too quick she is light headed; Her equilibrium is off; This is a spontaneous report from a contactable consumer, the patient. A 77-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot EL9263, first dose) solution for injection intramuscular in the right arm on 26Jan2021 (at the age of 77-years-old) as a single dose for COVID-19 vaccination. There was no medical history. Concomitant medication included lisinopril for blood pressure. The patient did not receive any other vaccine within 4 weeks prior to the vaccine. The patient felt a little dizzy if she bends down / if she moves too quick she is lightheaded and her equilibrium was off on 27Jan2021. There was no emergency room or physician office. The outcome of the events dizziness and equilibrium loss was not recovered.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Heart rate, Heart rate increased, Pain in extremity, Palpitations
Clinical narrative: 18-20 hours after receiving the injection he noticed that "his heart would beat "hard"/heart beating fast; about 18 to 20 hours later the next morning he was experiencing something like a palpitation; arm hurt that night and the next morning/sore arm of course; This is a spontaneous report from a contactable consumer (patients wife).   A 76-years-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot Number: EL9261) , via an unspecified route of administration on 21Jan2021 at 14:30 (at the age of 76-years-old) in the left arm  as SINGLE DOSE for covid-19 vaccination. Medical history included cardiac murmur and Type 2 Diabetic. There were no concomitant medications.  On 21Jan2021 the patient experienced arm hurt that night and the next morning/sore arm, and On 22Jan2021, 18-20 hours after receiving the injection he noticed that 'his heart would beat hard' /heart beating fast/he was experiencing something like a palpitation. Report described that it is like when you get scared. This Happens 2-3 times a day and it is not constant. The patient  went to his primary care physician on Friday for a 'routinely scheduled annual check up' and  mentioned this to her at his appointment. His provider encouraged him to call Pfizer and report these symptoms. His doctor is going to continue to follow up with him and if the problem persists do further tests. Lab data included heart rate on 22Jan2021 18-20 hours after injection his heart would beat hard /would be fast/something like a palpitation. The clinical outcome of heart beating fast was not recovered while palpitations and arm pain were unknown.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Headache, Influenza, Pain, Pyrexia
Clinical narrative: Fever of 101; body aches like the flu; headache; like the flu; This is a spontaneous report from a contactable health care professional, the patient.  A 53-years-old female  non-pregnant female patient (health care professional) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot Number: EK 9231), via an unspecified route of administration in the right arm on  25Jan2021 at 14:30 (at the age of 53-years-old) as a single dose, for COVID-19 vaccination. Facility where the most COVID-19 vaccine was administered was a Nursing Home/Senior Living Facility. Medical history included breast cancer on an  unspecified date (Breast cancer survivor) and Covid-19 on an unspecified date (Prior to vaccination, the patient was diagnosed with COVID-19).  Concomitant medication included escitalopram oxalate (LEXAPRO), tamoxifen (TAMOXIFEN). The patient had no known allergies. No other vaccines were given within 4 weeks. Since the vaccination the patient had not been tested for COVID-19. On 26Jan2021, The patient experienced fever of 101,  body aches,  like the flu, headache. The events were considered non serious.  The patient underwent lab tests and procedures which included body temperature:101 fahrenheit (fever 101) on 26Jan2021. No treatment was given for the events.   The clinical outcome of the events Fever of 101, body aches like the flu, headache was recovering.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Dehydration, Diarrhoea, Malaise, Nausea
Clinical narrative: diarrhea; He supposed that he is dehydrated; nausea; feeling unwell; chills; This is a spontaneous report from a contactable consumer (patient). A 71-years-old male patient received the first dose BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), lot EL3246 , unspecified route of administration on 21Jan2021 13:10 (at the age of 71-years old) as a SINGLE DOSE given in left arm for COVID-19 vaccination. Medical history included ongoing vertigo, ongoing dizziness, ongoing balance problems, ongoing vision problems, ongoing stomach problems, he lost 80lbs in a year, but his weight is starting to go back up. He has had bad health for the last 3 years. He goes to the doctors all the time. In fact, he just went to the ear, nose and throat (ENT) to find out what was going on. He has had dizziness quite often, so there are days where he just don't feel good but, he thinks it has something to do with his eyes. When he feels bad, he will lay down and close his eyes, and all of his problems go away. He went to see a retina specialist because of his continuing vision problems. The ENT doctor told him he can't help him. Concomitant medications included 6 different medications.  The patient experienced side effects after getting the first dose of the vaccine. He got the first dose a week ago and he said that he experienced nausea, feeling unwell, chills and diarrhea. The patient experienced nausea, feeling unwell, chills in Jan2021 and diarrhea on 26Jan2021. He had his shot a week ago tomorrow. He was up all night last night with diarrhea, he was up probably up 10 times. He was supposed to go in to get his teeth pulled today, but he just can't do it. He does have some chills and nausea. He is feeling unwell. He supposed that he is dehydrated in Jan2021. The diarrhea just started last night, 26Jan2021. He got up about 6:15 this morning and that was the last time he had diarrhea. He still has nausea, but he hasn't had any other diarrhea. He has some nausea from the time to time. He doesn't have any COVID symptoms that he can tell. He is feeling unwell, and has the nausea and chills, but he does not have any fever. He hasn't had a fever and he can still smell and taste and all of that stuff. One thing he did notice after he got his COVID-19 shot was that he did not have any symptoms of any kind. He never had pain in his arm, nothing. He received the vaccine on 21Jan2021, and he never felt a thing or anything that would associate with the shot. The consumer doesn't know if what he is going through is caused by the shot or not. Outcome of the events was unknown.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Lethargy, Nausea, Pain
Clinical narrative: The next day I felt intense lethargy; Soreness of the injection site; Dizzy; Light-headed/ Light headedness; Intense chills; Shaking; Feverish; Nausea; Body aches; This 25- year-old female patient contactable other HCP (reported for herself) received the second dose of COVID-19 vaccine (UNSPECIFIED TRADE NAME)(lot EL3247; expiration not provided), via an unspecified route of administration, on 25Jan2021 at 10:00 AM (at the age of 25-years-old) as a single dose for COVID-19 immunization. The facility where COVID-19 vaccine was administered was at a hospital and anatomically located on the left arm. Patient is not pregnant. The patient received the first dose of COVID-19 vaccine (UNSPECIFIED TRADE NAME)(lot EL0142; expiration not provided), via an unspecified route of administration, on 04Jan2021 at 11:00 AM (at the age of 25-years-old) as a single dose for COVID-19 immunization. Medical history included: allergies to: Azithromicin, raw fruit (apples, peaches, pears, plums, cherries, apricot). Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 25Jan2021 at 11:00pm, she reported "Within the first 15 min I felt dizzy and light-headed, that subsided after that. Around 12hours later I had intense chills, shaking, feverish, nausea and body aches. This lasted for around 5 hours, no medication was taken to treat. The next day I felt intense lethargy and light-headedness. The day after the lethargy continued with body-aches and continued soreness of the injection site" The clinical outcome of the events dizzy, light-headed, intense chills, shaking, feverish, nausea was recovering; the outcome of the events lethargy, body-aches, continued soreness of the injection site was not recovered.   No follow-up attempts are possible. No further information is expected.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Tremor, Vaccination site pain
Clinical narrative: The next day I felt intense lethargy; Soreness of the injection site; Dizzy; Light-headed/ Light headedness; Intense chills; Shaking; Feverish; Nausea; Body aches; This 25- year-old female patient contactable other HCP (reported for herself) received the second dose of COVID-19 vaccine (UNSPECIFIED TRADE NAME)(lot EL3247; expiration not provided), via an unspecified route of administration, on 25Jan2021 at 10:00 AM (at the age of 25-years-old) as a single dose for COVID-19 immunization. The facility where COVID-19 vaccine was administered was at a hospital and anatomically located on the left arm. Patient is not pregnant. The patient received the first dose of COVID-19 vaccine (UNSPECIFIED TRADE NAME)(lot EL0142; expiration not provided), via an unspecified route of administration, on 04Jan2021 at 11:00 AM (at the age of 25-years-old) as a single dose for COVID-19 immunization. Medical history included: allergies to: Azithromicin, raw fruit (apples, peaches, pears, plums, cherries, apricot). Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 25Jan2021 at 11:00pm, she reported "Within the first 15 min I felt dizzy and light-headed, that subsided after that. Around 12hours later I had intense chills, shaking, feverish, nausea and body aches. This lasted for around 5 hours, no medication was taken to treat. The next day I felt intense lethargy and light-headedness. The day after the lethargy continued with body-aches and continued soreness of the injection site" The clinical outcome of the events dizzy, light-headed, intense chills, shaking, feverish, nausea was recovering; the outcome of the events lethargy, body-aches, continued soreness of the injection site was not recovered.   No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Pain in extremity
Clinical narrative: After she got the vaccine this pain in her knee increased; sore arm; This is a spontaneous report from a contactable consumer, the patient.  A female patient of an unspecified age received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot number unknown), via an unspecified route of administration on an unspecified date in Jan2021(at an unknown age) as a single dose for COVID-19 vaccination. Medical history was reported as arthritis, hip and knee pain which she attributed to the cold weather. The patient's historical vaccinations included the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot number unknown) on an unspecified date for COVID-19 immunization. Concomitant medications were not provided. The reporter stated that, on an unspecified date in Jan2021 (reported as "last Monday") she got the second dose of "the COVID shot." Prior to this she had arthritis and hip and knee pain which she attributed to the cold weather. After she got the vaccine this pain in her knee increased and she also experienced a sore arm which went away two days after. The clinical outcomes of knee pain increased was reported as unknown. The clinical outcome of sore arm was reported as resolved on an unspecified date in Jan2021.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Dyspnoea, SARS-CoV-2 test
Clinical narrative: intense upper stomach pains (difficult time bending over, etc); Difficult time breathing/shortness of breath; This is a spontaneous report from a contactable healthcare professional. This 27-year-old non-pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; lot number EL3247) intramuscularly in the left arm on 25Jan2021 (at the age of 27-years-old) at 09:00 as a single dose for COVID-19 immunization. The patient's medical history was not reported. The patient had no known allergies. Prior to vaccination the patient was not diagnosed with COVID-19. Concomitant medication included escitalopram oxalate (LEXAPRO) from an unknown date for an unknown indication, dicyclomine from an unknown date for an unknown indication, doxycycline from an unknown date for an unknown indication, levothyroxine from an unknown date for an unknown indication, birth control from an unknown date for an unknown indication and women's multivitamins from an unknown date for an unknown indication. The patient had not received any other vaccine within 4 weeks prior to the vaccine. On 26Jan2021 at 08:00 the patient experienced intense upper stomach pains (difficult time bending over, etc.). Additionally, she experienced a difficult time breathing/shortness of breath. The patient reported the events resulted in an emergency room or urgent care visit. It was unknown if the patient received treatment for the events. The clinical outcomes of intense upper stomach pains (difficult time bending over, etc.) and a difficult time breathing/shortness of breath were recovering. It was also reported that since the vaccination the patient had tested negative for COVID-19 on 26Jan2021 via nasal swab and polymerase chain reaction tests.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Sinusitis
Clinical narrative: sinus infection; This is a spontaneous report from a contactable consumer (patient). A 67-year-old female patient received dose 1 of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number and Expiration date was unspecified) via an unspecified route of administration on 23Jan2021 (at the age of 67 years old) in a single dose for COVID-19 immunisation.  No Medical history or concomitant medication reported.   The patient experienced sinus infection on an unspecified date.  The patient was prescribed Cefdinir 300mg, twice daily and Methylprednisolone 4mg once daily for 7days. The patient wanted to check about the medications that her doctor has given her for the sinus infection to see if it will override the effects of the COVID vaccine. Outcome of event sinus infection was unknown.   The lot number for the vaccine BNT162B2 was not provided and will be requested during follow up.
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Condition aggravated, Fatigue, Headache, Illness
Clinical narrative: headache/ headachy; muscle aches; sore throat; sore arm; I felt worse; fever of 99.8; just felt overall very sick - flulike; just felt overall very sick - flulike; remaining very fatigued and slightly headachy; This is a spontaneous report from a contactable nurse (patient). This 68-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number EL8982; dose 2) intramuscularly on 26Jan2021 at 13:00 (at the age of 68-years-old) as a single dose in the left arm for COVID-19 immunization. Medical history included prolactinoma and osteoporosis. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior of the vaccine. The patient did not have COVID-19 prior to vaccination. Concomitant medications included vitamin D3 and bromocriptine (PARLODEL) from unknown dates for unknown indications. The patient had no known allergies. The patient previously received BNT162B2 (dose 1; lot number EL0142; left arm) on 05Jan2021 at 13:00. The patient felt fine until 26Jan2021 at 22:00- bedtime. She woke up during the night with a headache, muscle aches, sore throat, and sore arm. She tried to sleep it off but when she awoke at 07:00 she felt worse and had a fever of 99.8 and felt overall very sick- flulike. The patient was treated with ibuprofen. The patient started feeling better by about 14:00 "the next day" (unspecified) although she remained very fatigued and slightly "headachy." The clinical outcomes of headache, muscle aches, sore throat, sore arm, fever, flulike symptoms, and fatigue were recovered. It was also reported that since the vaccination, the patient had not been tested for COVID-19.   No follow-up attempts are needed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Influenza like illness, Myalgia, Oropharyngeal pain, Pain in extremity, Pyrexia
Clinical narrative: headache/ headachy; muscle aches; sore throat; sore arm; I felt worse; fever of 99.8; just felt overall very sick - flulike; just felt overall very sick - flulike; remaining very fatigued and slightly headachy; This is a spontaneous report from a contactable nurse (patient). This 68-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number EL8982; dose 2) intramuscularly on 26Jan2021 at 13:00 (at the age of 68-years-old) as a single dose in the left arm for COVID-19 immunization. Medical history included prolactinoma and osteoporosis. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior of the vaccine. The patient did not have COVID-19 prior to vaccination. Concomitant medications included vitamin D3 and bromocriptine (PARLODEL) from unknown dates for unknown indications. The patient had no known allergies. The patient previously received BNT162B2 (dose 1; lot number EL0142; left arm) on 05Jan2021 at 13:00. The patient felt fine until 26Jan2021 at 22:00- bedtime. She woke up during the night with a headache, muscle aches, sore throat, and sore arm. She tried to sleep it off but when she awoke at 07:00 she felt worse and had a fever of 99.8 and felt overall very sick- flulike. The patient was treated with ibuprofen. The patient started feeling better by about 14:00 "the next day" (unspecified) although she remained very fatigued and slightly "headachy." The clinical outcomes of headache, muscle aches, sore throat, sore arm, fever, flulike symptoms, and fatigue were recovered. It was also reported that since the vaccination, the patient had not been tested for COVID-19.   No follow-up attempts are needed. No further information is expected.
Age: 60.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Ageusia, Renal pain, Vaccination site pain
Clinical narrative: Loss of taste; right kidney pain severe; injection site pain; This is a spontaneous report from a contactable consumer (patient). This 60-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; dose 1) via an unspecified route of administration on 25Jan2021 at 10:00 (at the age of 60-years-old) as a single dose in the left arm for COVID-19 immunization. Medical history included chronic back pain, scoliosis, kidney stones, 3 double hernias, venous deficiency, fibromyalgia, 2 torn ligaments right foot, diabetes, and diabetic neuropathy. The patient did not receive any other vaccines within four weeks prior to the vaccine. The patient did not have COVID-19 prior to vaccination. The patient received unspecified concomitant medications. The patient previously took morphine from an unknown date for an unspecified indication and experienced allergy. On 25Jan2021 at 10:15 the patient experienced loss of taste, right kidney pain severe, and injection site pain. The patient was not treated for the events. The outcome of the events was not recovered. It was also reported that since the vaccination, the patient had not been tested for COVID-19.   The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow-up.
Age: 60.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Ageusia, Immediate post-injection reaction, Nausea, Peripheral swelling, Pyrexia
Clinical narrative: Loss of taste; right kidney pain severe; injection site pain; This is a spontaneous report from a contactable consumer (patient). This 60-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; dose 1) via an unspecified route of administration on 25Jan2021 at 10:00 (at the age of 60-years-old) as a single dose in the left arm for COVID-19 immunization. Medical history included chronic back pain, scoliosis, kidney stones, 3 double hernias, venous deficiency, fibromyalgia, 2 torn ligaments right foot, diabetes, and diabetic neuropathy. The patient did not receive any other vaccines within four weeks prior to the vaccine. The patient did not have COVID-19 prior to vaccination. The patient received unspecified concomitant medications. The patient previously took morphine from an unknown date for an unspecified indication and experienced allergy. On 25Jan2021 at 10:15 the patient experienced loss of taste, right kidney pain severe, and injection site pain. The patient was not treated for the events. The outcome of the events was not recovered. It was also reported that since the vaccination, the patient had not been tested for COVID-19.   The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow-up.
Age: 60.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Renal pain
Clinical narrative: Loss of taste; right kidney pain severe; injection site pain; This is a spontaneous report from a contactable consumer (patient). This 60-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; dose 1) via an unspecified route of administration on 25Jan2021 at 10:00 (at the age of 60-years-old) as a single dose in the left arm for COVID-19 immunization. Medical history included chronic back pain, scoliosis, kidney stones, 3 double hernias, venous deficiency, fibromyalgia, 2 torn ligaments right foot, diabetes, and diabetic neuropathy. The patient did not receive any other vaccines within four weeks prior to the vaccine. The patient did not have COVID-19 prior to vaccination. The patient received unspecified concomitant medications. The patient previously took morphine from an unknown date for an unspecified indication and experienced allergy. On 25Jan2021 at 10:15 the patient experienced loss of taste, right kidney pain severe, and injection site pain. The patient was not treated for the events. The outcome of the events was not recovered. It was also reported that since the vaccination, the patient had not been tested for COVID-19.   The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow-up.
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Headache, Lethargy, Myalgia
Clinical narrative: Lathargic; headache; muscle ache; chills; This is a spontaneous report from a contactable consumer (Patient). A 40-year-old male patient received first dose of BNT162B2 (COVID 19, Pfizer/BionTech, Solution for injection, Lot number: EN5318), via an unknown route administration on 26Jan2021 12:00 on left arm at single dose for Covid-19 immunization at Workplace clinic. The patient didn't received any other vaccines within 4 weeks prior to the COVID vaccine. No allergies to medications, food, or other products was reported. Concomitant medications the patient received within 2 weeks of vaccination included bupropion (buproprion), buprenorphine hydrochloride (SUBUTEX) and trazodone (trazadone). On 26Jan2021 at 18:00, the patient experienced lathargic, headache, muscle ache, chills. No treatment was received for the events. Prior to vaccination, the patient wasn't diagnosed with COVID-19. Since the vaccination, the patient hasn't been tested for COVID-19. Outcome of events at the time of last observation was recovering.  Information regarding lot/batch number has been requested.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Body temperature increased, Dizziness, Feeling hot, Hyperhidrosis
Clinical narrative: got dizzy; felt queasy; Temp was lightly elevated; Sore injection site; Could not sleep, very uncomfortable.; Got hot and sweaty about 3 1/2 hours after shot.; Got hot and sweaty about 3 1/2 hours after shot.; administration_date=26Jan2021; other vaccine date = 26Jan2021; administration_date=26Jan2021; other vaccine date = 26Jan2021; This is a spontaneous report from a contactable consumer (patient). A 63-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: unknown) via an unknown route of administration on left arm (L shoulder/Arm) on 26Jan2021 at 09:00 AM at the age of 63 years old at a single dose for COVID-19 immunization. Patient was not pregnant at the time of vaccination. Medical history included RA (Rheumatoid arthritis), Penicillin allergy and covid-19 (The patient was diagnosed with COVID-19 prior to vaccination). Concomitant medications included leflunomide (ARAVA) at 20mg, once a day, daily vitamins and mesalamine 1/day. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received other medications within 2 weeks of vaccination. Also reported administration date 26Jan2021; other vaccine date 26Jan2021. On 26Jan2021 09:00, the patient experienced sore injection site (shot was given very high on L shoulder/Arm). Felt like a sharp pain when given. Got hot and sweaty about 3 and an half hours after shot. Could not sleep, very uncomfortable. Next morning (on 27Jan2021), the patient was getting ready to eat breakfast and got dizzy and felt queasy. Temp was lightly elevated. Taking Tylenol to help control soreness. The patient assessed the events as non-serious. No treatment was received in response to the adverse event. Since the vaccination, the patient hasn't been tested for COVID-19. The outcome of the events administration_date=26Jan2021; other vaccine date = 26Jan2021 was unknown and patient was recovering from all other events.  Information on the lot/batch number has been requested.